Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study

✍ Scribed by Cozzolino, M.; Ketteler, M.; Martin, K. J.; Sharma, A.; Goldsmith, D.; Khan, S.

• Book ID: 121681801
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 341 KB
• Volume: 29
• Category: Article
• ISSN: 0931-0509
• DOI: 10.1093/ndt/gfu011